SKIN vs. INMD, IRMD, BBNX, EMBC, TNDM, AXGN, CLPT, SIBN, BVS, and AVNS
Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include InMode (INMD), iRadimed (IRMD), Beta Bionics (BBNX), Embecta (EMBC), Tandem Diabetes Care (TNDM), AxoGen (AXGN), ClearPoint Neuro (CLPT), SiBone (SIBN), Bioventus (BVS), and AVANOS MEDICAL (AVNS). These companies are all part of the "medical equipment" industry.
Beauty Health vs. Its Competitors
Beauty Health (NASDAQ:SKIN) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.
InMode has a net margin of 44.50% compared to Beauty Health's net margin of -6.13%. InMode's return on equity of 18.38% beat Beauty Health's return on equity.
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 41.0% of Beauty Health shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Beauty Health has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, InMode has a beta of 2.09, indicating that its stock price is 109% more volatile than the S&P 500.
Beauty Health presently has a consensus price target of $2.81, indicating a potential upside of 67.41%. InMode has a consensus price target of $18.04, indicating a potential upside of 19.09%. Given Beauty Health's higher possible upside, analysts clearly believe Beauty Health is more favorable than InMode.
InMode has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.
In the previous week, Beauty Health had 9 more articles in the media than InMode. MarketBeat recorded 12 mentions for Beauty Health and 3 mentions for InMode. Beauty Health's average media sentiment score of 1.02 beat InMode's score of 0.84 indicating that Beauty Health is being referred to more favorably in the media.
Summary
InMode beats Beauty Health on 9 of the 14 factors compared between the two stocks.
Get Beauty Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beauty Health Competitors List
Related Companies and Tools
This page (NASDAQ:SKIN) was last updated on 10/6/2025 by MarketBeat.com Staff
